Welcome to CDC stacks | Accounting for differences in healthcare utilization and expenditures among US males with haemophilia by type of health insurance - 46141 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Accounting for differences in healthcare utilization and expenditures among US males with haemophilia by type of health insurance
Filetype[PDF-316.24 KB]


Details:
No Related Documents.
You May Also Like:
  1. Health care expenditures for Medicaid-covered males with haemophilia in the United States, 2008
    Personal Author:
    GUH, S.; GROSSE, S. D.; MCALISTER, S.; KESSLER, C. M.; SOUCIE, J. M.;
    Published:
    Dec 21 2011
    Source:
    Haemophilia. 18(2):276-283.
    Description:
    Although haemophilia is an expensive disorder, no studies have estimated health care costs for Americans with haemophilia enrolled in Medicaid as distinct from those with employer-sponsored insurance (ESI). The objective of this study is to provide i...
    File Type:
    Filetype[PDF - 306.80 KB]
  2. Healthcare expenditures for males with haemophilia and employer-sponsored insurance in the United States, 2008
    Personal Author:
    GUH, S.; GROSSE, S. D.; McALISTER, S.; KESSLER, C. M.; SOUCIE, J. M.;
    Published:
    Dec 12 2011
    Source:
    Haemophilia. 18(2):268-275.
    Description:
    Although hemophilia has a potentially high economic impact, published estimates of health care costs for Americans with hemophilia are sparse and non-specific as to the non-bleeding complications of the disease. The objective of this study is to esti...
    File Type:
    Filetype[PDF - 360.90 KB]
  3. The effects of joint disease, inhibitors and other complications on health-related quality of life among males with severe haemophilia A in the United States
    Personal Author:
    Soucie, J. M.; Grosse, S. D.; Siddiqi, A.-E.-A.; Byams, V.; Thierry, J.; Zack, M. M.; Shapiro, A.; Duncan, N.;
    Published:
    Jun 02 2017
    Source:
    Haemophilia. 23(4):e287-e293.
    Description:
    Introduction : Health-related quality of life (HRQoL) is reduced among persons with haemophilia. Little is known about how HRQoL varies with complications of haemophilia such as inhibitors and joint disease. Estimates of preference-based HRQoL measur...
    File Type:
    Filetype[PDF - 88.32 KB]
  4. Prophylaxis use among males with haemophilia B in the United States
    Personal Author:
    Ullman, M.; Zhang, Q. C.; Grosse, S. D.; Recht, M.; Soucie, J. M.;
    Published:
    Aug 06 2017
    Source:
    Haemophilia. 23(6):910-917.
    Description:
    Introduction : Prophylaxis is considered the optimal treatment for persons with moderate to severe haemophilia (factor activity between 1–5% of normal and <1% of normal respectively) in countries where safe factor concentrates are available and eco...
    File Type:
    Filetype[PDF - 229.97 KB]
  5. National Center on Birth Defects and Developmental Disabilities annual report, Fiscal Year 2012
    Corporate Author:
    National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Office of the Director.
    Published:
    5/15/13
    Description:
    Promoting the health of babies, children, and adults and enhancing the potential for full, productive living.
    File Type:
    Filetype[PDF - 1.16 MB]